PRKCB and B-cell non-Hodgkin lymphoma: The best-studied is PKCβ inhibitor Enzastaurin, which has been tested alone or in combination with other chemotherapeutic drugs to treat glioma, lung cancer, ovary cancer, T and B cell lymphomas, colorectal cancer and other types of cancer [26, 50].